Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03367702
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Who this might be right for
Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology 692
Not applicableStudy completedNCT03963739
What this trial is testing

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage II Prostate Cancer+1 more
Wake Forest University Health Sciences 255
Testing effectiveness (Phase 2)Active Not RecruitingNCT01994239
What this trial is testing

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

Who this might be right for
Adenocarcinoma of Prostate
UNICANCER 120
Not applicableUnknownNCT02446366
What this trial is testing

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Adenocarcinoma
University of Southern California 24
Testing effectiveness (Phase 2)Ended earlyNCT00536991
What this trial is testing

Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage III Prostate Cancer+1 more
Roswell Park Cancer Institute 51
Testing effectiveness (Phase 2)Study completedNCT01433913
What this trial is testing

Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT01434290
What this trial is testing

Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate CancerPsychosocial Effects of Cancer and Its TreatmentRadiation Toxicity+1 more
Radiation Therapy Oncology Group 255
Testing effectiveness (Phase 2)Study completedNCT00390468
What this trial is testing

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerPainProstate Cancer
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT01117935
What this trial is testing

Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage I Prostate CancerStage II Prostate Cancer+2 more
Virginia Commonwealth University 55
Testing effectiveness (Phase 2)Ended earlyNCT01163084
What this trial is testing

Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage IIA Prostate Cancer AJCC v7Stage IIB Prostate Cancer AJCC v7
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)WithdrawnNCT00811031
What this trial is testing

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003781
What this trial is testing

Docetaxel in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
PainProstate Cancer
OHSU Knight Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT02058706
What this trial is testing

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
Barbara Ann Karmanos Cancer Institute 71
Not applicableStudy completedNCT02225925
What this trial is testing

Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Not applicableStudy completedNCT01368055
What this trial is testing

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 361
Not applicableLooking for participantsNCT06325046
What this trial is testing

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Mayo Clinic 164
Testing effectiveness (Phase 2)Temporarily pausedNCT00127088
What this trial is testing

Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris 37
Testing effectiveness (Phase 2)Study completedNCT00752739
What this trial is testing

Selenium in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Arizona 220
Testing effectiveness (Phase 2)Ended earlyNCT00019695
What this trial is testing

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerBone MetastasesAdenocarcinoma of the Prostate+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01026623
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 16
Next Page